The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Is The Forecasted Market Size Trajectory Of The Hemoglobin A1c Testing Devices Market From 2026 To 2030?
The hemoglobin a1c testing devices market has experienced significant growth in recent years. It is anticipated to expand from $2.08 billion in 2025 to $2.32 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 11.7%. This historic growth can be attributed to several factors, including the increasing prevalence of diabetes, the broader adoption of routine blood glucose monitoring practices, improved accessibility to laboratory diagnostics, a rising awareness of glycemic control, and the implementation of standardized diabetes testing protocols.
The market for hemoglobin a1c testing devices is projected to experience substantial expansion over the coming years. This market is anticipated to reach $3.53 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 11.1%. Factors contributing to this growth during the forecast period include the increasing demand for home-based diabetes monitoring, the rising integration of AI-driven analytics, the expansion of remote patient monitoring, a growing emphasis on personalized diabetes care, and the increasing adoption of smart diagnostic devices. Key trends observed throughout the forecast period encompass the increasing adoption of point-of-care hba1c testing, the rising utilization of portable and handheld devices, the growing integration with digital diabetes management platforms, the expansion of rapid and high-accuracy assays, and an enhanced focus on patient-centric monitoring.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9077&type=smp
Which Strong Drivers Are Impacting The Hemoglobin A1c Testing Devices Market Growth?
The expansion of the hemoglobin A1C testing devices market is anticipated to be driven by the increasing incidence of diabetes. This condition, a persistent metabolic disorder, leads to elevated blood glucose. Hemoglobin A1C testing offers insights into individuals’ average blood glucose, vital for diagnosing type 2 diabetes, pre-diabetes, and managing the disease, thereby empowering patients to track their condition and guide treatment choices to avert complications. An example comes from June 2024, where the National Health Service, a government department based in the UK, reported that in 2023, the NHS identified an additional 549,000 individuals in England at risk of type 2 diabetes. This increased the total number of people with non-diabetic hyperglycemia, or pre-diabetes, registered with a GP to 3,615,330. This marks a notable rise from 3,065,825 recorded in 2022, indicating an increase of nearly 20%. Consequently, the growing number of diabetes patients will fuel the hemoglobin A1C testing devices market.
What Are The Different Segment Types In The Hemoglobin A1c Testing Devices Market Segment Breakdown?
The hemoglobin a1c testing devices market covered in this report is segmented –
1) By Type: Bench Top Device, Handheld Device
2) By Technology: Ion-Exchange HPLC, Immunoassay, Boronate Affinity Chromatography, Direct Enzymatic Assay, Other Technologies
3) By End Use: Hospitals, Pharmaceuticals, Medical Devices, Laboratory Testing
Subsegments:
1) By Bench Top Device: Automated Hemoglobin A1C Analyzers, Laboratory-Grade Analyzers, Multi-Parameter Testing Devices
2) By Handheld Device: Portable Hemoglobin A1C Testers, Point-Of-Care Testing Devices, Smartphone-Integrated Testing Devices
Which Trends Are Contributing To Changes In The Hemoglobin A1c Testing Devices Market?
Leading companies in the hemoglobin A1c testing devices market are prioritizing the development of innovative solutions, such as at-home or micro-sample HbA1c collection kits. This initiative addresses the increasing demand driven by the rising prevalence of diabetes, the shift towards decentralized care and telehealth, and patients’ preference for convenient, more affordable monitoring options. An at-home HbA1c collection kit offers a consumer-friendly method, allowing patients to perform a small finger-prick blood collection, stabilize the micro-sample for transport, and send it to a certified laboratory for highly accurate analysis. For example, in February 2023, Hurdle, a US-based diagnostics-as-a-service company, launched its Hemoglobin A1c (HbA1c) Test, made accessible through its Chronomics direct-to-consumer store. The Hemoglobin A1c Test is provided as a home collection kit that includes finger-prick lancets and a sample card/tube, secure registration via a personal dashboard, and courier return to partner CLIA-certified laboratories. This service ensures lab-grade analysis with a typical turnaround of about three days following lab receipt, alongside integrated result explanations and optional one-to-one access to healthcare professionals for follow-up, thereby combining the convenience of point-of-care or home sampling with the accuracy and standardization of central laboratory assays.
Who Are The Well-Known Companies In The Hemoglobin A1c Testing Devices Market?
Major companies operating in the hemoglobin a1c testing devices market are Arkray Inc, Abbott Laboratories, Polymer Technology Systems Inc, Bio-Rad Laboratories Inc, Menarini Group, F Hoffmann-La Roche AG, Siemens Healthineers AG, Tosoh Corporation, Trinity Biotech plc, Transasia Bio-Medicals Limited, Beckman Coulter Inc, Diazyme Laboratories Inc, EKF Diagnostics Holdings plc, HemoCue AB, OSANG Healthcare Co Ltd, Danaher, Thermo Fisher Scientific Inc., PTS Diagnostics India Private Limited, Nova Biomedical, Randox Laboratories Ltd., ACON Laboratories Inc., DiaSys Diagnostic Systems GmbH, Erba Mannheim, Green Cross Medical Science Corp., Infopia Co. Ltd., TaiDoc Technology Corporation, Werfen, Zhejiang Orient Gene Biotech Co. Ltd.
Get The Full Hemoglobin A1c Testing Devices Market Report:
Which Region Has The Greatest Market Share In The Hemoglobin A1c Testing Devices Market?
North America was the largest region in the hemoglobin A1C testing devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the hemoglobin A1C testing devices market during the forecast period. The regions covered in the hemoglobin a1c testing devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Hemoglobin A1c Testing Devices Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/customise?id=9077&type=smp
Browse Through More Reports Similar to the Global Hemoglobin A1c Testing Devices Market 2026, By The Business Research Company
Hemoglobin A1C Hba1C Testing Market Report 2026
https://www.thebusinessresearchcompany.com/report/hemoglobin-a1c-hba1c-testing-global-market-report
Hemoglobin Testing Market Report 2026
https://www.thebusinessresearchcompany.com/report/hemoglobin-testing-global-market-report
Hematocrit Test Devices Market Report 2026
https://www.thebusinessresearchcompany.com/report/hematocrit-test-devices-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model